LC-1016

N/A

Report date: 2026/04/22 20:01:10
NME

Base Information

Drug NameLC-1016
Drug Alias NameLC-1016LC1016
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperlipoproteinemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Xinzhenghe Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Xinzhenghe Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperlipoproteinemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A